Font: Financial Modeling Prep • Aug 25, 2026
Nike (NYSE:NKE) is a global leader in athletic footwear, apparel, and equipment. The company faces challenges from tough competition and economic pressures. These factors contribute to sluggish sales in key markets like North America and Europe, and soft demand for brands such as Converse, as noted by The Motley Fool.
On August 25, 2026, analyst firm Jefferies confirmed its "Buy" rating for Nike when the stock price was $39.68. The news, published by TheFly, suggests that Jefferies considers a recent significant drop in the stock's price as a potential opportunity for investors to buy in at a lower cost.
This view comes as Nike trades at a 12-year low after its stock fell over 75% in the last five years. The company is working to stabilize its business. It is expanding Nike Direct, which includes its own e-commerce and physical stores, to rely less on wholesale retail partners for its sales.
The company's turnaround is taking longer than the market expected, as highlighted by The Motley Fool. Despite recent revenue declines, Nike is focused on speeding up innovation. If its strategy is successful, the company could see better profitability over the next several years, which would help support its dividend payments.
A key indicator for investors is the company's forward dividend yield of approximately 4%. A dividend yield shows the return an investor gets from dividends relative to the stock price. Nike's yield is notably higher than Coca-Cola (NYSE:KO)'s 2.4%, suggesting the market may be undervaluing the stock ahead of a potential recovery.
|
DCX§>
Digital Currency X Technology Inc.
|
$0.06
-17.85%
|
|
RETO§>
ReTo Eco-Solutions, Inc.
|
$0.17
4.67%
|
|
ATCH§>
AtlasClear Holdings, Inc.
|
$0.19
-0.81%
|
|
GLND§>
Greenland Energy Company Common Stock
|
$5.35
83.85%
|
|
ATYR§>
aTyr Pharma, Inc.
|
$0.34
-10.02%
|
|
INTC§>
Intel Corp.
|
$127.39
3.91%
|
|
ONDS§>
Ondas Holdings Inc.
|
$7.60
2.70%
|
|
CTNT§>
Cheetah Net Supply Chain Service Inc.
|
$0.03
-16.41%
|
|
TWG§>
Top Wealth Group Holding Limited Ordinary Shares
|
$0.21
-23.96%
|
|
APUS§>
Apimeds Pharmaceuticals US, Inc
|
$4.92
114.85%
|